Dusan Stojkovic

If you’ve been diagnosed with cancer, or know someone who has, you know the desperation: Dusan Stojkovic is a researcher, writer, and long-time advocate for alternative and complementary approaches to cancer and chronic disease.

Born in Yugoslavia, a country that no longer exists, he was exposed to cancer at an early age, losing close family members by the time he was eleven. These experiences sparked a lifelong search for answers beyond conventional medicine.

Fenbendazole Ivermectin Methylene Blue CBD What Your Doctor Did Not Tell You

About Alternative Cancer Therapies: Stojkovic, Dusan: Amazon.com: Books

Part of: What Your Doctor Did Not Tell You … (9 books)

by Dusan Stojkovic (Author)

Discover Hope and Healing: Your Guide to Alternative Cancer Therapies: What if everyday drugs like a dog dewormer, an anti-parasitic, and a simple dye could hold the key to fighting cancer?

In a groundbreaking episode of The Joe Rogan Experience, Mel Gibson revealed a jaw-dropping story: three of his friends, battling terminal cancer, turned to a private clinic using fenbendazole, ivermectin, and methylene blue—and all emerged cancer-free. This isn’t science fiction; it’s sparking a global conversation about affordable, repurposed treatments that challenge conventional oncology.

“What now? What else can I try?”

Enter Fenbendazole, Ivermectin, Methylene Blue, CBD:

What your doctor did not tell you about alternative cancer therapies —the ultimate FAQ guide to alternative and complementary cancer therapies, compiled from real-life success stories and four decades of community wisdom.

Author Dusan Stojkovic has been at the forefront of alternative medicine since 1993. He founded CureZone.org, a pioneering website with over 1,000 forums dedicated to natural healing, and administers some of the largest social media groups where hundreds of thousands share their journeys.

These aren’t just theories; they’re survivor tales from people told “there’s nothing more we can do”—yet they defied the odds. This book cuts through the confusion with clear, actionable answers to your burning questions:

What is the Fenbendazole protocol?

(The dog dewormer disrupts cancer cells, popularized by Joe Tippens’ viral recovery.)

How does Ivermectin fight cancer? (Inducing cell death in tumors while boosting other treatments.)

What’s the role of Methylene Blue? (Enhancing mitochondrial health and targeting cancer with photodynamic therapy.)

Can CBD and cannabis oil trigger cancer cell apoptosis?
How to combine protocols safely, including water fasting, ketogenic diets, liver flushes, coffee enemas, Essiac tea, and soursop?

Where to source these therapies affordably and legally?
What really causes cancer, and how to address root issues?
And much more—thousands of insights drawn from real experiences.

Why this book?

Because fenbendazole is more than a pet med, ivermectin goes beyond parasites, and these low-cost options may work synergistically to weaken tumors while protecting healthy cells. Backed by emerging studies and anecdotal triumphs, it’s your empowering resource when time is critical.

Each standalone chapter lets you dive in anywhere, but if cancer is progressing fast, start with Chapters 1–10 for immediate protocols. Whether you’re exploring options alongside conventional care or seeking alternatives, this book offers hope, strategies, and inspiration.

Ivermectin, Fenbendazole and Mebendazole Protocol in Cancer: Peer-Reviewed Protocol in Cancer, Ivermectin shows potential anticancer properties through various mechanisms, but there is currently no clinical evidence supporting its effectiveness in treating cancer in humans.

Don’t wait—empower your fight today. Grab your copy and join the thousands who’ve found new paths to healing. (3) Are you new to Alternative Cancer… – The Wellness Coach Dushan | Facebook

Mechanisms of Action
Disruption of Cancer Cell Signaling: Ivermectin may interfere with key signaling pathways involved in cancer cell growth and survival. It has been shown to inhibit tumor cell proliferation and induce apoptosis (programmed cell death) in laboratory studies.

Ionophore Activity: Ivermectin acts as an ionophore, facilitating the transport of chloride ions across cell membranes. This mechanism can create oxidative stress in cancer cells, leading to their death while sparing healthy cells.

Mitochondrial Disruption: The drug can inhibit mitochondrial function, which is crucial for cancer cells that have high energy demands. By reducing ATP production, ivermectin deprives cancer cells of energy, triggering stress responses that can lead to cell death.

Immune Modulation: Ivermectin has been observed to enhance immune responses, potentially improving the body’s ability to target and eliminate cancer cells. This includes boosting the activity of natural killer cells and macrophages.

Inhibition of Angiogenesis: The drug may also inhibit the formation of new blood vessels that tumors need to grow, thereby limiting their nutrient and oxygen supply.

Current Research Status
While there is growing interest in ivermectin as a potential cancer treatment, most studies have been conducted in vitro (in cell cultures) or in animal models, and there is a lack of robust clinical evidence in humans. Some preliminary studies suggest that ivermectin may have a role as an adjunct to established cancer therapies, but these findings are not yet conclusive.

Caution and Considerations
Experts warn that claims of ivermectin as a cancer cure are not supported by clinical trials and that using it outside of approved indications could lead to harmful side effects. High doses of ivermectin can cause serious health issues, and patients are advised to rely on proven cancer treatments.

In summary, while ivermectin exhibits several mechanisms that could theoretically impact cancer cells, further research is necessary to determine its safety and efficacy as a cancer treatment in humans.

Fact Check: Can Ivermectin and Fenbendazole Help Treat Cancer?

Rethinking Cancer: Fenbendazole, Mebendazole, and Ivermectin

In recent years, there has been growing interest in repurposing existing drugs for the treatment of cancer.

One such drug is Ivermectin, a widely used medication primarily known for its efficacy against parasitic infections. However, emerging evidence suggests that Ivermectin may have potential anticancer properties as well. In this blog post, we delve into the intriguing connection between Ivermectin and cancer, exploring the findings presented in a study published on the National Center for Biotechnology Information (NCBI) website.

The study referenced in the article, titled “Ivermectin as a potential cancer therapeutic: An insight into its molecular targets and possible mechanisms of action,” sheds light on the potential anticancer effects of Ivermectin. It suggests that the drug may exhibit various mechanisms of action that could impede cancer cell growth and survival.

One mechanism highlighted in the study is Ivermectin’s ability to inhibit tumor cell proliferation. The drug appears to interfere with key signaling pathways involved in cell cycle progression, ultimately leading to the suppression of tumor growth. Additionally, Ivermectin has demonstrated the potential to induce apoptosis, or programmed cell death, in cancer cells, thereby inhibiting their survival and spread.

Another intriguing aspect of Ivermectin’s anticancer potential lies in its ability to modulate the immune response. The drug has been shown to enhance immune cell activity, such as natural killer cell cytotoxicity and macrophage function, leading to improved immune-mediated tumor cell clearance. This immunomodulatory effect suggests that Ivermectin could potentially complement existing immunotherapy strategies for cancer treatment.

Furthermore, the study highlights the drug’s ability to inhibit angiogenesis, the process by which new blood vessels form to support tumor growth. By disrupting the formation of new blood vessels, Ivermectin may hinder the nutrient and oxygen supply to cancer cells, ultimately impeding their survival and metastasis.

drpetesulack

Ivermectin: The Cancer Support Tool No One Saw Coming: https://www.instagram.com/drpetesulack/reel/DLVC-KGM4pX/

When I was handed a terminal diagnosis, I didn’t go looking for a cure—I went looking for terrain disruption. Ivermectin stood out: Dr. Pete Sulack on Repurposed Drugs and Hope for the Future of Cancer Care – Journey to Wellness

Here’s what the science says:
• Frontiers in Oncology (2022): Ivermectin downregulates PAK1 and angiogenesis
• Biochemical Pharmacology: Disrupts mitochondrial energy production in tumor cells
• Dr. William Makis: Highlights blood-brain barrier penetration and glioma case success

I used it in rotation.
Stacked with detox, oxygen, fasting, and metabolic support.
It didn’t cure me. But it helped rebuild the terrain so my body could fight.

Now? I’m in remission. And I’m here to help others reclaim their hope too.